ARMP vs GILD: Which Stock is Better?

Side-by-side comparison of Armata Pharmaceuticals Inc and Gilead Sciences Inc in 2026

Comparison Updated:

ARMP

Armata Pharmaceuticals Inc

$10.60

GILD

Gilead Sciences Inc

$143.93

Key Metrics Comparison

MetricARMPGILDWinner
Market Cap$385.91M$178.68BGILD
P/E RatioN/A21.42GILD
EPS (TTM)$N/A$6.72GILD
Revenue Growth-0.6%0.0%GILD
Gross Margin-416.4%78.8%GILD

Analyze ARMP

Full quant analysis

Analyze GILD

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ARMP or GILD a better investment?

Comparing ARMP and GILD: Armata Pharmaceuticals Inc has a market cap of $385.91M while Gilead Sciences Inc has $178.68B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ARMP and GILD?

ARMP (Armata Pharmaceuticals Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ARMP or GILD?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ARMP or GILD?

GILD has higher revenue growth at 0.0% vs -0.6% for ARMP.

Which company is more profitable: ARMP or GILD?

Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to -416.4% for ARMP.

Which is the larger company: ARMP or GILD?

Gilead Sciences Inc (GILD) is larger with a market cap of $178.68B compared to $385.91M for ARMP.

Should I buy ARMP or GILD in 2026?

Both ARMP and GILD have investment merit. ARMP trades at $10.60 while GILD trades at $143.93. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ARMP and GILD stock?

Key differences: Market Cap ($385.91M vs $178.68B), P/E Ratio (N/A vs 21.4x), Revenue Growth (-0.6% vs 0.0%), Gross Margin (-416.4% vs 78.8%).

Popular Stock Comparisons